BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17610938)

  • 1. Measuring soluble CD40 ligand:interleukin-10 ratio as a prognostic marker in acute myocardial infarction: yet another prognostic biomarker?
    Jessani S; Lip GY
    Thromb Res; 2007; 121(3):289-91. PubMed ID: 17610938
    [No Abstract]   [Full Text] [Related]  

  • 2. Soluble CD40 ligand:interleukin-10 ratio predicts in-hospital adverse events in patients with ST-segment elevation myocardial infarction.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Kaski JC
    Thromb Res; 2007; 121(3):293-9. PubMed ID: 17521712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inflammatory and anti-inflammatory markers in acute coronary syndromes. Ready for use in the clinical setting?].
    García-Moll X
    Rev Esp Cardiol; 2005 Jun; 58(6):615-7. PubMed ID: 15970115
    [No Abstract]   [Full Text] [Related]  

  • 4. Diurnal variation of soluble CD40 ligand in patients with acute coronary syndrome. Soluble CD40 ligand and diurnal variation.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Kaski JC
    Thromb Res; 2009 Feb; 123(4):617-21. PubMed ID: 18579184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD40 ligand in acute coronary syndromes.
    Conde ID; Kleiman NS
    N Engl J Med; 2003 Jun; 348(25):2575-7; author reply 2575-7. PubMed ID: 12816111
    [No Abstract]   [Full Text] [Related]  

  • 6. The long-term prognostic value of multiple biomarkers following a myocardial infarction.
    Brügger-Andersen T; Aarsetøy H; Grundt H; Staines H; Nilsen DW
    Thromb Res; 2008; 123(1):60-6. PubMed ID: 18387656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation.
    Ferro D; Loffredo L; Polimeni L; Fimognari F; Villari P; Pignatelli P; Fuster V; Violi F
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2763-8. PubMed ID: 17901373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-10: biomarker or pathologic cytokine in fulminant myocarditis?
    Knowlton KU; Yajima T
    J Am Coll Cardiol; 2004 Sep; 44(6):1298-300. PubMed ID: 15364335
    [No Abstract]   [Full Text] [Related]  

  • 9. Does the pre-existing inflammation play a role in the increased C-reactive protein levels in acute myocardial infarction?
    Celik T; Iyisoy A; Kursaklioglu H; Turhan H; Isik E
    Int J Cardiol; 2006 Sep; 112(1):134-5; author reply 136-8. PubMed ID: 16647767
    [No Abstract]   [Full Text] [Related]  

  • 10. Is interleukin-10 the only predictor for inflammation?
    Aksun M; Kestelli M; Yurekli I; Karahan N
    Eur J Cardiothorac Surg; 2011 Mar; 39(3):429-30; author reply 430. PubMed ID: 20692846
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic utility of the soluble CD40 ligand in acute coronary syndrome.
    Lindberg S
    Coron Artery Dis; 2014 Nov; 25(7):548-9. PubMed ID: 25248136
    [No Abstract]   [Full Text] [Related]  

  • 12. Soluble CD40 ligand as a biomarker for storage-related preanalytic variations of human serum.
    Lengellé J; Panopoulos E; Betsou F
    Cytokine; 2008 Nov; 44(2):275-82. PubMed ID: 18851919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.
    Stumpf C; Petzi S; Seybold K; Wasmeier G; Arnold M; Raaz D; Yilmaz A; Daniel WG; Garlichs CD
    Clin Sci (Lond); 2009 Jan; 116(1):45-52. PubMed ID: 18459941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose: a biomarker in acute myocardial infarction ready for prime time?
    Nesto RW; Lago RM
    Circulation; 2008 Feb; 117(8):990-2. PubMed ID: 18299511
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease.
    Lim PS; Wu MY; Chien SW; Wu TK; Liu CS; Hu CY; Chang HC; Pai MA
    Nephrology (Carlton); 2008 Dec; 13(8):677-83. PubMed ID: 19019166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarction.
    Dominguez-Rodriguez A; Abreu-Gonzalez P
    Clin Cardiol; 2009 May; 32(5):288. PubMed ID: 19452490
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute myocardial infarction induced increases in plasma tumor necrosis factor-alpha and interleukin-10 are associated with the activation of poly(ADP-ribose) polymerase of circulating mononuclear cell.
    Yao L; Huang K; Huang D; Wang J; Guo H; Liao Y
    Int J Cardiol; 2008 Jan; 123(3):366-8. PubMed ID: 17689746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of microalbuminuria with inflammation markers in hypertensive men.
    Bautista LE
    Am J Hypertens; 2006 May; 19(5):467. PubMed ID: 16647615
    [No Abstract]   [Full Text] [Related]  

  • 19. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of megatroponinemia after myocardial infarction.
    Kalra N; Sattur S; Sorrell VL
    Am J Med; 2009 Apr; 122(4):392-4. PubMed ID: 19332235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.